Usually, patients are able to return to their regular activities right away following treatment
Therefore, as an expected extension of the theoretical framework concerning adverse effects [1], the extensive model complexities and the involvement of a multitude of biological targets [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168] should, axiomatically, be associated with the emergence of adverse outcomes
TNF Inhibitor Therapy for Psoriatic Arthritis As the beneficial effects of tumor necrosis factor (TNF) inhibitor therapy in rheumatoid arthritis (RA) became clear in the late 1990s, it was only a matter of time before interest grew in testing these agents in psoriatic arthritis (PsA), a disease widely perceived to have similar manifestations and pathophysiology
Constrained DRUJ replacement this has gained popularity recently